The US FDA has granted approval for Medtronic's OmniaSecure defibrillation lead intended for insertion in the right ventricular. The post Medtronic's defibrillation lead gains FDA approval for use in right ventricle appeared first on Medical Device Network.
Medtronic is an Ireland-based medical device company that manufactures and supplies therapeutic and diagnostic equipment to treat chronic diseases across the globe.